Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
Top Cited Papers
Open Access
- 10 May 2001
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (19) , 1434-1441
- https://doi.org/10.1056/nejm200105103441904
Abstract
Once-daily injections of parathyroid hormone or its amino-terminal fragments increase bone formation and bone mass without causing hypercalcemia, but their effects on fractures are unknown.Keywords
This publication has 28 references indexed in Scilit:
- Mice, Estrogen, and Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 1999
- Comparative calibration without a gold standardStatistics in Medicine, 1997
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control chartsJournal of Bone and Mineral Research, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993
- Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormoneJournal of Bone and Mineral Research, 1992
- Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patientsBone and Mineral, 1991
- Effects of Two Treatment Regimes with Synthetic Human Parathyroid Hormone Fragment on Bone Formation and the Tissue Balance of Trabecular Bone in GreyhoundsEndocrinology, 1983
- Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of Its Resorptive Action: Differential Effects of Intermittent and Continuous Administration*Endocrinology, 1982